IHH seeks up to $1.7b in compensation from JP’s Daiichi Sankyo over Fortis deal

Northern TK Venture filed a claim against Daiichi Sankyo saying the latter prevented NTK from proceeding with its open offer.

IHH Healthcare is seeking compensation of up to $1.7b (₹109.3b) from Japanese drugmaker Daiichi Sankyo for its stake buy in India’s Fortis Healthcare.

In 2018, IHH bought a 31.1% controlling stake in Fortis Healthcare for $618m (₹40b), allowing an open offer to acquire another 26% of Fortis shares from the market.

However, IHH terminated its offer after a court ruling ordered the status quo to be maintained concerning the sale of a controlling stake in Fortis Healthcare to NTK be maintained after Daiichi Sankyo filed a contempt plea against Fortis Healthcare's founders.

In 2023, IHH’s subsidiary Northern TK Venture (NTK) filed a claim against Daiichi Sankyo saying the latter prevented NTK from proceeding with its open offer to acquire a stake in Fortis Healthcare.

At that time, NTK sought an initial claim of ¥20b ($178m) from Daiichi Sankyo as damages with an interest rate of 3% per annum.

NTK-appointed consultant Osborne Partners said the compensation ranges from $60m (RM200m) to $1.7b (RM5.7b).

“NTK reserves its rights to amend its claim for damages, including to add other heads of loss and/or to claim the costs of the legal fees it is seeking from Daiichi Sankyo,” it added.

A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia

Top News

Specialty chemicals manufacturing facility on Jurong Island for sale

The fully equipped facility is clean and ready to be recommissioned.

Commercial Property

9 hours ago

September surge masks looming export slowdown to 6% in 2027

Maybank raised its 2026 forecast to 27% from 18% in the same report.Non-oil domestic exports (NODX) growth could slow to 6% in 2027 as supply chain pressures and higher financing costs weigh on shipment momentum, Maybank Research Pte Ltd said.

Economy

12 hours ago

Nearly half of workers report six or more unpaid hours a week, report says